AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Resmed DRC

37.510

+0.1800.48%

Volume:160.84K

Turnover:6.02M

Market Cap:55.00B

PE:29.49

High:37.580

Open:37.330

Low:37.150

Close:37.330

Loading ...

Overview Company News Filings

Why Breville, Flight Centre, Orica, and ResMed shares are dropping today

Resmed Chief Commercial Officer Offloads $2.3 Million Worth of Shares

MT Newswires Live

Resmed Consolidating Brands, Product Lines Under Single Name

MT Newswires Live

Resmed CFO Sells Over $200,000 Worth of Shares

MT Newswires Live

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

ResMed Inc. Stock Rises Monday, Outperforms Market

Resmed CEO Sells $1.8 Million Worth of Shares

MT Newswires Live

No savings at 50? I'd buy ASX 200 shares and aim to retire rich

ResMed Inc. Stock Rises Friday, Outperforms Market

How to turn $500 into $50,000 of passive income a year with ASX shares

VEEV Stock Gains Following Latest Availability of HCP Access Data

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed

Resmed Founder Offloads Shares Worth $500,000; Shares Down 3%

MT Newswires Live

Resmed Inc : Citi Upgrades Rating to Buy From Neutral, Hikes Price Target to a$44.00 From a$41.00

THOMSON REUTERS

2 ASX healthcare shares rated as top buys

ResMed's Reasonable Valuation Lures New Bull -- Market Talk

ResMed Inc. Stock Falls Wednesday, Underperforms Market

ResMed Raised to Buy From Neutral by Citigroup

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RMD.AU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RMD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","market":"AU","secType":"STK","nameCN":"Resmed DRC","latestPrice":37.51,"timestamp":1746587889078,"preClose":37.33,"halted":0,"volume":160844,"delay":0,"nameEN":"Resmed DRC","floatShares":145691036,"shares":1466188140,"eps":1.2718135290127641,"marketStatus":"Trading","change":0.18,"latestTime":"05-07 13:18:13 AEST","open":37.33,"high":37.58,"low":37.15,"amount":6017638,"amplitude":0.011519,"askPrice":37.53,"askSize":203,"bidPrice":37.51,"bidSize":183,"shortable":3,"etf":0,"ttmEps":1.2718135290127641,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746597600000},"marketStatusCode":2,"adr":0,"adrRate":1,"exchange":"ASX","adjPreClose":37.33,"dividendRate":0.008096,"openAndCloseTimeList":[[1746576000000,1746597600000]],"volumeRatio":0.35266,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RMD.AU\",,,,,undefined,":{"symbol":"RMD.AU","floatShares":145691036,"roa":"14.01%","roe":"25.81%","lyrEps":0.963495,"volumeRatio":0.35266,"shares":1466188140,"dividePrice":0.303694,"high":37.58,"amplitude":0.011519,"preClose":37.33,"low":37.15,"week52Low":26.887,"pbRate":"6.43","psRate":"7.10","week52High":40.571,"institutionHeld":0,"latestPrice":37.51,"committee":-0.051813,"eps":1.2718135290127641,"divideRate":0.008096,"volume":160844,"delay":0,"ttmEps":1.2718135290127641,"open":37.33,"prevYearClose":36.61,"prevWeekClose":37.179,"prevMonthClose":36.6,"prevQuarterClose":34.884,"fiveDayClose":36.6,"twentyDayClose":33.787,"sixtyDayClose":37.526},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RMD.AU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518086009","title":"Why Breville, Flight Centre, Orica, and ResMed shares are dropping today","url":"https://stock-news.laohu8.com/highlight/detail?id=2518086009","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518086009?lang=en_us&edition=fundamental","pubTime":"2025-03-12 08:48","pubTimestamp":1741740531,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is having another difficult session. At the time of writing, the benchmark index is down 1.6% to 7,765.3 points. Four ASX shares that are falling more than most today a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/12/why-breville-flight-centre-orica-and-resmed-shares-are-dropping-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","BK4585","RMD.AU","BK4082","LU0310800965.SGD","BK4008","BRG.AU","BK4548","FLT.AU","BK4588","IE00BFMHRM44.USD","BK7119","LU0128525689.USD","BK4504","BK4500","LU1267930227.SGD","ORI.AU","XJO.AU","BK7017","LU0052756011.USD","DAL","LU2177674079.SGD","BK4567","BK7007","BK7070","LU2008162690.USD","RMD"],"gpt_icon":1},{"id":"2518030167","title":"Resmed Chief Commercial Officer Offloads $2.3 Million Worth of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2518030167","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518030167?lang=en_us&edition=fundamental","pubTime":"2025-03-12 06:26","pubTimestamp":1741731997,"startTime":"0","endTime":"0","summary":"Resmed  Chief Commercial Officer Ghoshal Kaushik sold 9,745 of his shares in the company on the New York Stock Exchange, with an aggregate market value of $2.3 million, according to a Wednesday filing with the Australian bourse.Following the transaction, Kaushik owns nearly 146.9 million shares and other units outstanding in the company, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","LU2008162690.USD","XAO.AU","BK4588","BK4567","BK4585","BK4504","BK7501","RMD.AU","BK4082","LU2177674079.SGD","RMD","BK4548","BK7007","XKO.AU"],"gpt_icon":0},{"id":"2518821741","title":"Resmed Consolidating Brands, Product Lines Under Single Name","url":"https://stock-news.laohu8.com/highlight/detail?id=2518821741","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518821741?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:24","pubTimestamp":1741699444,"startTime":"0","endTime":"0","summary":"Resmed  early Tuesday disclosed plans to consolidate all of its brands, products, and services under the Resmed name over the next few years, creating a more streamlined view for both consumers and healthcare providers.The upcoming transformation will be accompanied by a new visual identity, redesigned logo and refreshed brand voice, the CPAP therapy company said, with the moves expected to reinforce its position as an approachable, people-centered and forward-thinking health technology company.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","LU2177674079.SGD","RMD","BK4082","BK7007","LU2008162690.USD","BK4585","RMD.AU","BK4548","BK4567","BK7501","BK4588"],"gpt_icon":1},{"id":"2518878256","title":"Resmed CFO Sells Over $200,000 Worth of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2518878256","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518878256?lang=en_us&edition=fundamental","pubTime":"2025-03-11 07:03","pubTimestamp":1741647780,"startTime":"0","endTime":"0","summary":"Resmed (ASX:RMD) Chief Financial Officer Brett Sandercock sold 1,000 shares in the company on the New York Stock Exchange for $230,360, according to a filing on Tuesday with the US Securities and Exchange Commission.Sandercock now holds about 146.9 million shares, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2177674079.SGD","BK4504","BK7007","BK4548","BK4567","RMD","LU2008162690.USD","RMD.AU","BK7501","BK4585","BK4082","BK4588"],"gpt_icon":0},{"id":"2518648785","title":"ResMed Among Top Stocks For Recent And Long-Term Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2518648785","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518648785?lang=en_us&edition=fundamental","pubTime":"2025-03-11 05:00","pubTimestamp":1741640400,"startTime":"0","endTime":"0","summary":"A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2024/04/Stock-Resmed-bldg-shutt-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/04/Stock-Resmed-bldg-shutt-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/resmed-trying-to-close-in-on-key-technical-measure/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1791710582.SGD","BK7501","LU0353189680.USD","BK4581","LU0823416689.USD","LU2265009873.SGD","LU0528227936.USD","LNTH","LU0114720955.EUR","LU2491049909.HKD","LU2491050154.USD","IE00B2B36J28.USD","RS","BK4548","PEN","LU2506952170.USD","IE0002141913.USD","LU2506951875.HKD","RMD","LU0823417737.USD","LU2242649171.HKD","BK4567","IE00BFTCPJ56.SGD","LU0267386448.USD","LU1791710400.SGD","LU1989772923.USD","RMD.AU","LU0238689110.USD","LU1291159041.SGD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4006","LU1983299246.USD","LU2244417387.USD","LU1153585028.USD","LU2506951958.HKD","BSX","LU1718418525.SGD","PEN.AU","BSX.AU","IE00BJJMRZ35.SGD","LU2087625088.SGD","BK7083","LU0345769631.USD","LU0950375773.USD","IE00B4R5TH58.HKD","LU2506952097.USD","LU0266013472.USD","LU0882574055.USD","BK4588"],"gpt_icon":1},{"id":"2518785131","title":"ResMed Inc. Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2518785131","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518785131?lang=en_us&edition=fundamental","pubTime":"2025-03-11 04:57","pubTimestamp":1741640220,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  rallied 1.80% to $236.63 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 2.70% to 5,614.56 and Dow Jones Industrial Average  falling 2.08% to 41,911.71.This was the stock's third consecutive day of gains.ResMed Inc. closed 10.04% below its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  eclipsed its 50-day average volume of 916,881.Data source: Dow Jones Market Data, FactSet. Data compiled March 10, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2518823635","title":"Resmed CEO Sells $1.8 Million Worth of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2518823635","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518823635?lang=en_us&edition=fundamental","pubTime":"2025-03-10 05:59","pubTimestamp":1741557549,"startTime":"0","endTime":"0","summary":"Resmed  Chief Executive Michael Farrell sold 8,009 of his shares in the company on the New York Stock Exchange, with an aggregate market value of about $1.8 million, according to a Monday filing with the Australian bourse.Following the transaction, Farrell owns nearly 146.9 million shares and other units outstanding in the company, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4082","XAO.AU","BK4567","LU2177674079.SGD","BK7501","XJO.AU","BK7007","BK4548","RMD","XKO.AU","RMD.AU","LU2008162690.USD","BK4588","BK4504"],"gpt_icon":0},{"id":"2517446418","title":"No savings at 50? I'd buy ASX 200 shares and aim to retire rich","url":"https://stock-news.laohu8.com/highlight/detail?id=2517446418","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517446418?lang=en_us&edition=fundamental","pubTime":"2025-03-08 06:00","pubTimestamp":1741384800,"startTime":"0","endTime":"0","summary":"If you've reached 50 with little or no savings, retirement might seem like a scary prospect. But don't panic—there's still time to build wealth and secure a comfortable future.  In fact, the vast majo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/08/no-savings-at-50-id-buy-asx-200-shares-and-aim-to-retire-rich/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4585","LU0267386448.USD","LU0912757837.SGD","XRO.AU","BK4581","BK7016","BK7503","LU2133065610.SGD","LU1720051108.HKD","LU0158827781.USD","LU0098860793.USD","LU1989772923.USD","BK4516","BK4534","LU1074936037.SGD","BK4504","LU2111349929.HKD","LU0795875086.SGD","LU1162221912.USD","LU1548497426.USD","LU1720051017.SGD","LU2028103732.USD","LU2357305700.SGD","LU1732800096.USD","LU2271345857.HKD","LU2089284900.SGD","LU0158827948.USD","IE00BKVL7J92.USD","LU0006306889.USD","LU0106831901.USD","LU0795875169.SGD","COH.AU","BK7501","LU1732799900.SGD","LU0320765646.SGD","LU0971096721.USD","BK4588","LU0314104364.USD","LU0225283273.USD","LU1363072403.SGD","LU2023251221.USD","IE00BZ1G4Q59.USD","LU2089283258.USD","RMD.AU","LU2347655156.SGD","LU1989772840.SGD","BK7007","LU1668664300.SGD","LU0106261372.USD","BK4127"],"gpt_icon":1},{"id":"2517469654","title":"ResMed Inc. Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469654","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517469654?lang=en_us&edition=fundamental","pubTime":"2025-03-08 05:56","pubTimestamp":1741384560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  advanced 3.29% to $232.44 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.55% to 5,770.20 and the Dow Jones Industrial Average  rising 0.52% to 42,801.72.This was the stock's second consecutive day of gains.ResMed Inc. closed 11.64% below its 52-week high of $263.05, which the company achieved on January 30th.Trading volume  remained 51,777 below its 50-day average volume of 959,860.Data source: Dow Jones Market Data, FactSet. Data compiled March 7, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2517464189","title":"How to turn $500 into $50,000 of passive income a year with ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2517464189","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517464189?lang=en_us&edition=fundamental","pubTime":"2025-03-08 04:34","pubTimestamp":1741379640,"startTime":"0","endTime":"0","summary":"Building wealth and generating passive income through ASX shares is a long-term game, but with a combination of consistency and the right strategy, it could lead to financial freedom. By investing jus","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/08/how-to-turn-500-into-50000-of-passive-income-a-year-with-asx-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7503","BK7007","IVV.AU","BK7021","BK7511","BK7042","BK4534","AX1.AU","TLS.AU","BK4588","BK7510","RMD.AU","BK7016","BK7501","XRO.AU","VHY.AU","BK4581","BK4585","GMG.AU","BK7099","BK7155","VOO","FDN","BK4559","BK4550","NDQ.AU"],"gpt_icon":0},{"id":"2517451285","title":"VEEV Stock Gains Following Latest Availability of HCP Access Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2517451285","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517451285?lang=en_us&edition=fundamental","pubTime":"2025-03-08 00:56","pubTimestamp":1741366560,"startTime":"0","endTime":"0","summary":"Veeva Systems Inc. VEEV, on Tuesday, announced Veeva CRM Pulse. It is a data subscription that provides quarterly healthcare professional  access and multichannel engagement metrics for the life sciences industry.Pulse is currently available for license to Veeva Systems’ CRM customers with 2024 quarterly data covering the United States, Canada, Germany, United Kingdom, France, Italy, Spain, Portugal, Austria, Switzerland, Netherlands, Belgium, Ireland, Hungary, Brazil, Mexico, Australia, New Zealand, South Korea, Taiwan and Singapore. Quarterly data releases for 2025 are expected to begin this April. Additional countries in Asia and Europe are currently being planned for availability next year.The latest availability is expected to significantly enhance the Veeva Data Cloud product category, thus boosting its overall business.Following the announcement, shares of the company gained nearly 7.9% till yesterday’s closing.Veeva Systems currently has a market capitalization of $38.34 billio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/veev-stock-gains-following-latest-165600596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LU0642271901.SGD","RMD.AU","LU1061106388.HKD","VEEV","LU0820562030.AUD","HCP","LU0889566641.SGD","LU1267930227.SGD","LU2362541513.USD","IE00BFTCPJ56.SGD","LU0130102774.USD","LU2265009873.SGD","LU0353189763.USD","RMD","LU0106261372.USD","LU0251132253.USD","LU0267386448.USD","BSX.AU","LU0109392836.USD","LU1291159041.SGD","LU0823417737.USD","LU1023059063.AUD","LU1803068979.SGD","LU0792757196.USD","LU1804176565.USD","BK7007","IE0009355771.USD","LU0211328371.USD","IE00BQXX3C00.GBP","LU2491050071.SGD","LU2506951875.HKD","BK4527","SG9999001440.SGD","LU1057294990.SGD","LU0058720904.USD","BSX","LU2458330169.SGD","LU2244417387.USD","IE00B4R5TH58.HKD","LU2361044865.SGD","LU2506952170.USD","LU0345769631.USD","CAH","BK4175","LU0511384066.AUD","BK4528","BK4613","LU0943347566.SGD","LU0234570918.USD"],"gpt_icon":1},{"id":"2517362604","title":"Is it Worth Adding ResMed Stock to Your Portfolio Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517362604","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517362604?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:11","pubTimestamp":1741353060,"startTime":"0","endTime":"0","summary":"ResMed Inc.’s RMD growth in the second quarter of fiscal 2025 can be attributed to the robust performance of its Mask business. Its Device sales continue to drive overall revenue growth. The company’s SaaS business growth is driven by strategic buyouts. However, the increasing debt burden on ResMed’s operations remains a concern.In the past year, shares of this Zacks Rank #2  company have surged 16.9%, outperforming the industry’s 9.2% growth and the S&P 500 composite’s 14.5% rise.The renowned medical device company has a market capitalization of $32.87 billion. RMD has an earnings yield of 4.2%, outpacing the industry’s 1.5%. The company’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 6.86%.Robust Mask Sales: ResMed continues to see strong demand for its market-leading mask portfolio, gaining from a competitor’s recall. Continued product development is driving growth within this business globally. The company has successfully int","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/worth-adding-resmed-stock-portfolio-131100726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1804176565.USD","BSX","LU0528227936.USD","LU2491050154.USD","LU0823417737.USD","PAHC","LU2362540622.SGD","LU1718418525.SGD","LU2265009873.SGD","IE0002141913.USD","LU0114720955.EUR","LU0823416689.USD","LU0128525689.USD","LU0889566641.SGD","BK4082","LU0048584097.USD","LU2324357040.USD","LU2087625088.SGD","LU2177674079.SGD","LU0211327993.USD","IE00BFTCPJ56.SGD","LU2362541513.USD","LU2506951958.HKD","LU0266013472.USD","IE0009355771.USD","BK4504","LU2244417387.USD","LU2491049909.HKD","RMD.AU","CAH","LU0792757196.USD","LU0238689110.USD","LU0310800965.SGD","LU1880398471.USD","BK4175","LU2506951875.HKD","RMD","BK4548","LU0077335932.USD","LU1983299246.USD","LU0122379950.USD","LU1571399168.USD","LU0011850046.USD","LU2506952170.USD","LU2362541273.HKD","LU0162691827.USD","SG9999001440.SGD","LU0072461881.USD","LU1791710400.SGD","BK4567","LU1023059063.AUD"],"gpt_icon":0},{"id":"2517318791","title":"Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed","url":"https://stock-news.laohu8.com/highlight/detail?id=2517318791","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517318791?lang=en_us&edition=fundamental","pubTime":"2025-03-06 15:06","pubTimestamp":1741244760,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 6, 2025 – Stocks in this week’s article are — Taiwan Semiconductor Manufacturing Company Ltd. TSM, Tapestry, Inc. TPR, ABM Industries ABM, Vertiv Holdings Co. VRT and ResMed Inc. RMD.5 Best Dividend-Growth Stocks to Buy Amid Trade-War Fears. Wall Street has been caught in a vicious circle of woes, led by recent tariff escalations and a slowdown in the economy. The U.S. stocks erased all the gains made post-election, and the S&P 500 is now at its lowest level since November when Trump won the Presidential election.In fact, stocks with a strong history of year-over-year dividend growth form a healthy portfolio with a greater scope of capital appreciation, as opposed to simple dividend-paying stocks or those with high yields. We have selected five dividend growth stocks — Taiwan Semiconductor Manufacturing Company Ltd., Tapestry, Inc., ABM Industries, Vertiv Holdings Co. and ResMed Inc. — which could be solid choices amid market volatility.New York-based Tapestry, whic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-com-featured-highlights-taiwan-070600569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LU1064131342.USD","LU2491049909.HKD","LU2237443622.USD","IE0004091025.USD","BK4534","IE00BN0W2W23.USD","BK4527","LU0128525689.USD","LU1868837565.USD","LU0823414551.USD","LU2211815571.USD","LU0823421416.USD","VRT.AU","LU1282649810.SGD","BK4602","LU0488056044.USD","VRT","LU1989772923.USD","LU2237443382.USD","IE00BQXX3F31.USD","BK4533","BK4554","SGXZ99366536.SGD","TPR","LU2360106780.USD","BK4096","LU0310800965.SGD","IE0004086264.USD","LU2750360997.AUD","LU1868838027.USD","ABM","RMD.AU","BK4504","03145","TSM","LU0109392836.USD","BK7007","IE00BYQQ9H92.USD","LU2133065610.SGD","LU1211504680.USD","LU0348723411.USD","BK4512","LU0124676726.USD","IE00BN0W2V16.EUR","LU0094547139.USD","LU2125154935.USD","RMD","LU0689626769.HKD","IE00BN0W2T93.GBP","LU1989764664.SGD"],"gpt_icon":1},{"id":"2517905425","title":"Resmed Founder Offloads Shares Worth $500,000; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517905425","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517905425?lang=en_us&edition=fundamental","pubTime":"2025-03-06 11:13","pubTimestamp":1741230781,"startTime":"0","endTime":"0","summary":"Resmed  founder Peter Farrell sold 2,000 of his shares in the company on the New York Stock Exchange, with an aggregate market value of $500,000, according to a Thursday filing with the Australian bourse.Following the transaction, Farrell owns nearly 146.9 million shares and other units outstanding in the company.Resmed's shares were down more than 3% in recent Thursday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","LU2177674079.SGD","RMD","BK4504","BK4082","BK4585","BK4588","BK4567","BK4548","BK7007","LU2008162690.USD","RMD.AU"],"gpt_icon":0},{"id":"2517970248","title":"Resmed Inc  : Citi Upgrades Rating to Buy From Neutral, Hikes Price Target to a$44.00 From a$41.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2517970248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517970248?lang=en_us&edition=fundamental","pubTime":"2025-03-06 10:11","pubTimestamp":1741227097,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nFWN3PO16S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2008162690.USD","BK7007","LU2177674079.SGD","BK4548","BK4082","BK7501","BK4585","BK4588","BK4504","RMD","BK4567","RMD.AU"],"gpt_icon":0},{"id":"2517790580","title":"2 ASX healthcare shares rated as top buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2517790580","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517790580?lang=en_us&edition=fundamental","pubTime":"2025-03-06 10:08","pubTimestamp":1741226887,"startTime":"0","endTime":"0","summary":"Investors looking at ASX healthcare shares have an entire sea of top-quality selections to choose from.  Two names, Pro Medicus Limited  and ResMed Inc.  are also rated highly by brokers at the time of writing.  Do they deserve a spot in your portfolio today?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/06/2-asx-healthcare-shares-rated-as-top-buys/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PME.AU","BK7094","BK7501","BK7007","RMD.AU"],"gpt_icon":0},{"id":"2517787689","title":"ResMed's Reasonable Valuation Lures New Bull -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2517787689","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517787689?lang=en_us&edition=fundamental","pubTime":"2025-03-06 07:09","pubTimestamp":1741216140,"startTime":"0","endTime":"0","summary":"2309 GMT - ResMed gets a new bull at Citi, where analyst Mathieu Chevrier points to the breathing-tech maker's strong EPS growth, free cash-flow and balance sheet. Raising his recommendation on ResMed's Australia-listed stock to buy from neutral, Chevrier values the company at 24 times projected fiscal 2026 earnings, in line with its pre-Covid average. Its current valuation of 22 times fiscal 2026 earnings therefore looks reasonable, he writes in a note. He points out that ResMed has seen little impact from the roll-out of new weight-loss drugs, and sees risks associated with such treatments being continuously pushed back. Citi lifts its target price 7.3% to A$44.00. Shares are at A$36.92 ahead of the open. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","BK4588","BK4504","RMD","BK4567","LU2008162690.USD","BK4548","BK4585","BK7501","LU2177674079.SGD","BK4082","BK7007"],"gpt_icon":1},{"id":"2517192273","title":"ResMed Inc. Stock Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192273","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517192273?lang=en_us&edition=fundamental","pubTime":"2025-03-06 05:55","pubTimestamp":1741211700,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of ResMed Inc.  slipped 3.30% to $223.83 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 1.12% to 5,842.63 and the Dow Jones Industrial Average  rising 1.14% to 43,006.59.This was the stock's third consecutive day of losses.ResMed Inc. closed 14.91% short of its 52-week high of $263.05, which the company reached on January 30th.Trading volume  eclipsed its 50-day average volume of 940,930.Data source: Dow Jones Market Data, FactSet. Data compiled March 5, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD","RMD.AU"],"gpt_icon":0},{"id":"2517949077","title":"ResMed Raised to Buy From Neutral by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2517949077","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517949077?lang=en_us&edition=fundamental","pubTime":"2025-03-06 00:19","pubTimestamp":1741191540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2025 11:19 ET (16:19 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RMD.AU","RMD"],"gpt_icon":0},{"id":"2517912801","title":"ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?","url":"https://stock-news.laohu8.com/highlight/detail?id=2517912801","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517912801?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:55","pubTimestamp":1741175700,"startTime":"0","endTime":"0","summary":"ResMedRMD has achieved impressive growth over the past year, with its shares rallying 25.6%. It has outperformed the industry’s 13.1% rise and the S&P 500 composite’s 15.7% gain.Presently carrying a Zacks Rank #2 , the renowned medical equipment company continues to gain from its widely adopted mask portfolio and strong device business. Expanding the Respiratory Care business with cutting-edge technologies and the momentum in the SaaS  business are also highly encouraging.San Diego, CA-based ResMed holds a major position as a designer, manufacturer and distributor in the worldwide market for generators, masks and related accessories for the treatment of sleep-disordered breathing  and other respiratory disorders.The company’s software solutions are geared toward the fragmented and underserved OOH  care market, where it sees significant opportunities for innovation. Acquisitions are also a key part of ResMed’s ongoing success.Investors are also upbeat about the company’s tendency for st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/resmed-stock-climbs-25-6-115500833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0240877869.USD","LU0823416689.USD","LU1983299246.USD","LU2177674079.SGD","IE00BJJMRZ35.SGD","BK4175","BK4581","LU1023059063.AUD","IE0002141913.USD","LU0006061336.USD","LU1291159041.SGD","IE00B2B36J28.USD","LU0353189680.USD","LU0052756011.USD","CAH","LU0353189763.USD","LU2764263039.SGD","BK4082","LU0077335932.USD","LU0266013472.USD","BK4585","LU0267386448.USD","MASI","LU1804176565.USD","LU0251132253.USD","RMD","LU2362541273.HKD","LU2491050154.USD","LU0345769128.USD","LU1267930227.SGD","LU1989772923.USD","LU1989771016.USD","LU0048584097.USD","BSX","LU0240878834.USD","LU0211327993.USD","LU1791710400.SGD","LU2242649171.HKD","LU2764263203.CNY","LU0162691827.USD","LU2720916845.USD","RMD.AU","LU2506952097.USD","LU0345769631.USD","SG9999001440.SGD","LU0205194284.USD","LU0211328371.USD","LU0889566641.SGD","LU1153585028.USD","LU0114720955.EUR"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RMD.AU\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-04-24","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-05-08","defaultRemindTime":1746576000000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-08","currency":"USD","dateTimestamp":1746540000000,"payDate":"2025-06-12"},{"date":"2025-02-12","symbol":"RMD.AU","amount":0.053,"announcedDate":"2025-01-31","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-13","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-13","currency":"USD","dateTimestamp":1739278800000,"payDate":"2025-03-20"},{"date":"2024-11-06","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-10-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-11-07","name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-11-07","currency":"USD","dateTimestamp":1730811600000,"payDate":"2024-12-12"},{"date":"2024-08-14","symbol":"RMD.AU","amount":0.053,"announcedDate":"2024-08-02","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-08-15","defaultRemindTime":1723593600000,"name":"Resmed DRC","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-19","payableDate":"2024-08-15","currency":"USD","dateTimestamp":1723557600000,"payDate":"2024-09-19"},{"date":"2024-05-08","symbol":"RMD.AU","amount":0.048,"announcedDate":"2024-04-26","type":"dividend","market":"AU","newRecordDate":"2024-05-09","defaultRemindTime":1715126400000,"name":"Resmed DRC","recordDate":"2024-06-13","payableDate":"2024-05-09","currency":"USD","dateTimestamp":1715090400000,"payDate":"2024-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RMD.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-08-19","recordDate":"2020-08-20","paymentDate":"2020-09-24","value":0.039,"currency":"USD"},{"executeDate":"2020-11-11","recordDate":"2020-11-12","paymentDate":"2020-12-17","value":0.039,"currency":"USD"},{"executeDate":"2021-02-10","recordDate":"2021-02-11","paymentDate":"2021-03-18","value":0.039,"currency":"USD"},{"executeDate":"2021-05-12","recordDate":"2021-05-13","paymentDate":"2021-06-17","value":0.039,"currency":"USD"},{"executeDate":"2021-08-18","recordDate":"2021-08-19","paymentDate":"2021-09-23","value":0.042,"currency":"USD"}]}}